Understanding Generics: How Does Bioequivalence Translate to Clinical Efficacy?

For Pharmacists


In this presentation, Dr. Thiessen examines the fundamental principles of bioequivalence as they relate to drug interchangeability, with a focus on human biology and intra-product variability. This presentation offers an overview of the criteria set by Health Canada on establishing bioequivalence between generic and brand products, and examines myths and facts that relate to bioequivalence. The presentation will deepen your understanding of bioequivalence and drug interchangeability, better enabling you to address common questions raised in your practice about this subject.

For those eligible, this web presentation has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP).


Jake J. Thiessen, Ph.D.
Chair, Health Canada Scientific Advisory Committee on Bioavailability and Bioequivalence; Founding Director, School of Pharmacy, University of Waterloo; Professor Emeritus, Leslie Dan Faculty of Pharmacy, University of Toronto

To review the presentation, please follow these steps:

Step 1: View Presentation

Step 2: View Q&A

Step 3: Complete Accreditation

The Canadian Council on Continuing Education in Pharmacy (CCCEP) has accredited this program for 1.5 CEUs. CCCEP File Number: 1160-2011-386-I-P

This program was sponsored through an unrestricted educational grant from Teva Canada Limited.
For more information on Teva Canada Limited, please visit

If you have any questions or concerns with this website, please email